Mind Medicine (MindMed) Inc

MNMD08 Dec 2024
Healthcare
$7.3
+0.05 (+4.64%)
Lowest Today
$7.28
Highest Today
$7.61
Today’s Open
$7.3
Prev. Close
$7.11
52 Week High
$12.22
52 Week Low
$2.92
To Invest in Mind Medicine (MindMed) Inc

Mind Medicine (MindMed) Inc

Healthcare
MNMD08 Dec 2024
+0.05 (+4.64%)
1M
3M
6M
1Y
5Y
Low
$7.28
Day’s Range
High
$7.61
7.28
52 Week Low
$2.92
52-Week Range
52 Week High
$12.22
2.92
1 Day
-
1 Week
-8.36%
1 month return
-12.04%
3 month return
+24.16%
6 month return
-5.33%
1 Year return
+132.81%
3 Years return
-75.29%
5 Years return
-
10 Years return
-
Institutional Holdings
COMMODORE CAPITAL LP
10.91
Deep Track Capital, LP
9.63
BlackRock Inc
7.34
Blackstone Inc
5.34
Driehaus Capital Management LLC
5.31
Octagon Capital Advisors LP
4.12
Marshall Wace Asset Management Ltd
3.12

Market Status

Fundamentals
Market Cap
545.59 mln
PB Ratio
2.08
PE Ratio
0
Enterprise Value
274.61 mln
Total Assets
124.54 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Organisation
Mind Medicine (MindMed) Inc
Employees
57
Industry
Biotechnology
CEO
Mr. Robert  Barrow
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities